| Market Cap | ₹1,023Cr |
| ROE | 13.86% |
| P/E Ratio(TTM) | 37.61 |
| EPS(TTM) | 6.58 |
| P/B Ratio | 6.15 |
| Dividend Yield | 0.16% |
| Industry P/E | 32.63 |
| Book Value | 40.28 |
| Debt to Equity | 0.05 |
| Face Value | 2 |
| Managing Director | Mr. Naresh Kumar Singla, Mr. Suresh Chand Singla |
| Founded | 1992 |
| BSE Symbol | 524717 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 101.56 | ||
| Anthem Biosciences | NA (0.00%) | 81.44 | ||
| Onesource Specialty Pharma | NA (0.00%) | 754.17 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 21.71 |